We are live on !
Find out more
Capital Analysts LLC Portfolio holdings
AUM
$4.34B
Turnover
9.37%
1-Year Est. Return
17.55%
This Fund
S&P 500
This Quarter Est. Return
-15.2%
1 Year Est. Return
+17.55%
3 Year Est. Return
+51.26%
5 Year Est. Return
+53.67%
10 Year Est. Return
+179.02%
AUM
$815M
AUM Growth
-$197M
(-19%)
Cap. Flow
-$25.2M
Cap. Flow % of AUM
Cap. Flow %
-3.09%
Top 10 Holdings %
Top 10 Hldgs %
42.66%
Holding
765
New
45
Increased
213
Reduced
221
Closed
86
Avg Time Held
2.7
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$39.5M |
| 2 |
Chevron
CVX
|
+$2.79M |
| 3 |
Johnson & Johnson
JNJ
|
+$2.74M |
| 4 |
NextEra Energy
NEE
|
+$1.44M |
| 5 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$1.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
|
+$11.3M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$10.4M |
| 3 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$7.34M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$6.94M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$3.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.34% |
| 2 | Technology | 6.95% |
| 3 | Healthcare | 5.62% |
| 4 | Financials | 3.9% |
| 5 | Industrials | 3.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Aon
AON
$62.1B
| $349K | 0.04% |
2,115
+95
| +5% | +$19.4K |
2013 Q2
27 quarters
|
|
177
IBM
IBM
$219B
| $323K | 0.04% |
3,045
+1,887
| +163% | +$239K |
2013 Q2
27 quarters
|
|
178
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.67B
| $321K | 0.04% |
6,682
+411
| +7% | +$20.2K |
2018 Q4
5 quarters
|
|
179
AbbVie
ABBV
$504B
| $313K | 0.04% |
4,111
+15
| +0.4% | +$1.28K |
2013 Q3
26 quarters
|
|
180
DELISTED
Ansys
ANSS
| $303K | 0.04% |
1,305
+23
| +2% | +$5.93K |
2018 Q4
5 quarters
|
|
181
Diamondback Energy
FANG
$57.1B
| $293K | 0.04% |
11,177
+14
| +0.1% | +$882 |
2016 Q3
14 quarters
|
|
182
State Street SPDR MSCI World StrategicFactors ETF
QWLD
$177M
| $289K | 0.04% |
4,190
-10,615
| -72% | -$860K |
2018 Q4
5 quarters
|
|
183
Marvell Technology
MRVL
$205B
| $277K | 0.03% |
+12,250
| New | +$294K |
2020 Q1
0 quarters
|
|
184
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $273K | 0.03% |
10,572
+900
| +9% | +$28.7K |
2018 Q4
5 quarters
|
|
185
Janus Henderson Short Duration Income ETF
VNLA
$3.56B
| $271K | 0.03% |
5,512
+350
| +7% | +$17.4K |
2018 Q2
7 quarters
|
|
|
EMCG
186
DELISTED
WisdomTree Emerging Markets Consumer Growth Fund
EMCG
| $270K | 0.03% |
15,200
+975
| +7% | +$21.2K |
2017 Q3
10 quarters
|
|
187
Sempra
SRE
$54.5B
| $269K | 0.03% |
4,768
+4
| +0.1% | +$284 |
2017 Q4
9 quarters
|
|
188
Target
TGT
$70.1B
| $269K | 0.03% |
2,897
+46
| +2% | +$5.11K |
2017 Q2
11 quarters
|
|
189
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.1B
| $264K | 0.03% |
6,775
+1,265
| +23% | +$57.5K |
2019 Q4
1 quarter
|
|
190
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $263K | 0.03% |
5,019
+441
| +10% | +$23.5K |
2013 Q2
27 quarters
|
|
191
ProShares UltraPro QQQ
TQQQ
$33.2B
| $262K | 0.03% |
44,000
-4,000
| -8% | -$41.9K |
2016 Q3
14 quarters
|
|
192
NVIDIA
NVDA
$5.17T
| $252K | 0.03% |
38,240
-2,600
| -6% | -$16.4K |
2015 Q2
19 quarters
|
|
193
Idexx Laboratories
IDXX
$44.1B
| $245K | 0.03% |
+1,010
| New | +$264K |
2020 Q1
0 quarters
|
|
194
Direxion Daily Healthcare Bull 3X ETF
CURE
$185M
| $239K | 0.03% |
6,000
| – | – |
2016 Q3
14 quarters
|
|
195
Regeneron Pharmaceuticals
REGN
$81.4B
| $239K | 0.03% |
490
+55
| +13% | +$22.7K |
2019 Q4
1 quarter
|
|
196
Verizon
VZ
$186B
| $236K | 0.03% |
4,387
+66
| +2% | +$3.78K |
2013 Q2
27 quarters
|
|
197
Copart
CPRT
$25.8B
| $232K | 0.03% |
+13,520
| New | +$301K |
2020 Q1
0 quarters
|
|
|
ALXN
198
DELISTED
Alexion Pharmaceuticals
ALXN
| $231K | 0.03% |
2,574
+600
| +30% | +$58.9K |
2018 Q1
8 quarters
|
|
199
West Pharmaceutical
WST
$27B
| $228K | 0.03% |
+1,495
| New | +$230K |
2020 Q1
0 quarters
|
|
200
iShares Select U.S. REIT ETF
ICF
$2.09B
| $227K | 0.03% |
4,966
+320
| +7% | +$17.9K |
2013 Q2
27 quarters
|
|
Similar funds
ZP
AIIMS
Capital Analysts LLC's Q1 2020 Portfolio in Review
As of Q1 2020, Capital Analysts LLC held 765 positions worth $815M, down 19% from $1.01B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Capital Analysts LLC withdrew a net $25.2M in Q1 2020, closing 86 positions and reducing 221 holdings. Its most notable exit was Synovus, an estimated $1.08M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, up from 69% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Capital Analysts LLC opened a new position in NextEra Energy worth $1.38M.
- Capital Analysts LLC's largest Q1 2020 buy was NextEra Energy: 22,944 shares worth $1.38M.
- Capital Analysts LLC added most to State Street SPDR Portfolio S&P 500 ETF in Q1 2020, an estimated $39.5M increase.
- Capital Analysts LLC's biggest Q1 2020 reduction was Invesco S&P 500 High Dividend Low Volatility ETF, cutting an estimated $11.3M.
- Capital Analysts LLC fully exited Synovus in Q1 2020, selling an estimated $1.08M.
- Capital Analysts LLC's ten largest holdings make up 43% of its $815M portfolio in Q1 2020.
- Capital Analysts LLC opened 45 new positions and closed 86 in Q1 2020.
- Capital Analysts LLC's portfolio value fell 19% quarter-over-quarter to $815M.
Based on Capital Analysts LLC's 13F filing for Q1 2020, filed 8 May 2020.